Athanase Innovation AB (STO:ATIN)
Sweden · Delayed Price · Currency is SEK 20.20
0.00 (0.00%)
Sep 21, 2026, 5:29 PM CET
Athanase Innovation AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 29.31 | 36.86 | 115.27 | 19.27 | 6.38 | 7.06 |
Other Revenue | 31.68 | 10.69 | 53.48 | 21.33 | -51.8 | 15 |
| 60.99 | 47.55 | 168.75 | 40.6 | -45.42 | 22.06 | |
Revenue Growth | -35.10% | -71.83% | 315.63% | - | - | - |
Cost of Revenue | 16.37 | 17.89 | 88.24 | 22.82 | 4.32 | 4.08 |
Gross Profit | 44.62 | 29.65 | 80.51 | 17.78 | -49.74 | 17.98 |
Selling, General & Admin | 89.62 | 86.26 | 91.92 | 87.13 | 70.64 | 22.54 |
Other Operating Expenses | -5.96 | -6.65 | -7.65 | -6.15 | -5.46 | -0.41 |
Operating Expenses | 94.58 | 93.73 | 97.92 | 95.52 | 80.67 | 33.58 |
Operating Income | -49.95 | -64.08 | -17.41 | -77.73 | -130.41 | -15.6 |
Interest Expense | -0.71 | -0.86 | -0.61 | -0.09 | -0.14 | -0.15 |
Interest & Investment Income | 5.34 | 6.54 | 13.03 | 16.35 | 3.63 | 2.89 |
Earnings From Equity Investments | -0.68 | -0.05 | -6.29 | -1.47 | - | - |
Currency Exchange Gain (Loss) | -0.03 | -0.03 | 0.15 | -4.28 | 2.06 | - |
Other Non Operating Income (Expenses) | 0.19 | 0.19 | - | - | - | - |
EBT Excluding Unusual Items | -45.84 | -58.28 | -11.14 | -67.22 | -124.86 | -12.85 |
Merger & Restructuring Charges | - | - | - | - | - | -17.5 |
Gain (Loss) on Sale of Investments | - | - | -8.5 | - | 1.25 | - |
Pretax Income | -45.84 | -58.28 | -19.64 | -67.22 | -123.62 | -30.35 |
Income Tax Expense | 0.04 | 0.33 | -0 | -10.96 | -9.09 | -3.8 |
Earnings From Continuing Operations | -45.88 | -58.62 | -19.64 | -56.26 | -114.53 | -26.55 |
Minority Interest in Earnings | 1.64 | 0.99 | - | - | - | - |
Net Income | -44.24 | -57.62 | -19.64 | -56.26 | -114.53 | -26.55 |
Net Income to Common | -44.24 | -57.62 | -19.64 | -56.26 | -114.53 | -26.55 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 19 | 19 | 24 | 30 | 31 | 31 |
Shares Outstanding (Diluted) | 19 | 19 | 24 | 30 | 31 | 31 |
Shares Change | -8.17% | -18.77% | -20.21% | -4.08% | - | 27.90% |
EPS (Basic) | -2.29 | -2.99 | -0.83 | -1.89 | -3.69 | -0.86 |
EPS (Diluted) | -2.29 | -2.99 | -0.83 | -1.89 | -3.69 | -0.86 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -67.69 | -67.46 | -16.45 | -83.58 | -44.64 | -14.95 |
Free Cash Flow Per Share | -3.51 | -3.50 | -0.69 | -2.81 | -1.44 | -0.48 |
Gross Margin | 73.16% | 62.37% | 47.71% | 43.80% | - | 81.49% |
Operating Margin | -81.90% | -134.78% | -10.32% | -191.46% | - | -70.68% |
Profit Margin | -72.52% | -121.19% | -11.64% | -138.58% | - | -120.34% |
Free Cash Flow Margin | -110.98% | -141.89% | -9.74% | -205.86% | - | -67.78% |
EBITDA | -39.74 | -50.66 | -3.97 | -63.42 | -114.98 | -4.14 |
EBITDA Margin | -65.15% | -106.55% | -2.35% | -156.19% | - | -18.79% |
D&A For EBITDA | 10.22 | 13.42 | 13.44 | 14.32 | 15.44 | 11.45 |
EBIT | -49.95 | -64.08 | -17.41 | -77.73 | -130.41 | -15.6 |
EBIT Margin | -81.90% | -134.78% | -10.32% | -191.46% | - | -70.68% |
Revenue as Reported | 67.8 | 54.86 | 176.83 | 47.08 | -39.84 | 22.56 |